Krsnaa Diagnostics Limited reported earnings results for the second quarter and six months ended September 30, 2024. For the second quarter, the company reported sales was INR 1,863.4 million compared to INR 1,554.49 million a year ago. Revenue was INR 1,909.34 million compared to INR 1,596.07 million a year ago. Net income was INR 195.96 million compared to INR 104.96 million a year ago. Basic earnings per share from continuing operations was INR 6.07 compared to INR 3.35 a year ago. Diluted earnings per share from continuing operations was INR 5.92 compared to INR 3.23 a year ago.
For the six months, sales was INR 3,565.72 million compared to INR 2,950.28 million a year ago. Revenue was INR 3,684.82 million compared to INR 3,034.08 million a year ago. Net income was INR 375.17 million compared to INR 251.39 million a year ago. Basic earnings per share from continuing operations was INR 11.62 compared to INR 8.01 a year ago. Diluted earnings per share from continuing operations was INR 11.38 compared to INR 7.73 a year ago.
Krsnaa Diagnostics Limited is an India-based company primarily engaged in the business of providing diagnostic services primarily in relation to pathology investigation, radiology investigation and tele reporting. The Company’s service offerings cover pathology, X-Ray, and computed tomography (CT) scan, magnetic resonance imaging (MRI), USG, tele-radiology, tele-pathology, and other diagnostic services. Its laboratory services span a diverse range of investigations, ranging from routine to highly specialized tests. Its teleradiology services enable radiologists to offer treatment remotely. Teleradiology involves transmitting radiological images, such as CT scans, digitized X-rays, MRIs and ultrasounds between different locations. It offers various health packages in addition to its Ayaksham package. It provides diagnostic testing packages for diabetes, heart health, liver health, kidney health, thyroid, fatigue, cancer, senior citizen care, bone health, infection screening, and more.
